Pvg Asset Management »

Anavex Life Sciences shares owned by Pvg Asset Management

Quarter-by-quarter ownership of Anavex Life Sciences (AVXL) shares owned by Pvg Asset Management from 13F filings

Historical chart of Pvg Asset Management investment in Anavex Life Sciences

Tip: Access up to 7 years of quarterly data

All positions including Anavex Life Sciences held by Pvg Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Anavex Life Sciences by Pvg Asset Management

Quarter filed Position value Share count Share price at filing
2024-12-31 $843k 79k 10.74
2024-09-30 $74k 13k 5.68

More positions owned by Pvg Asset Management

Nuveen S&P 500 Buy-Write Income Etf (BXMX)
Vanguard Index S&P 500 Etf (VOO)
ProShares Short S&P500 Etf (SH)
S&p 500 Indx Etf (IVV)
Anavex Life Sciences (AVXL)
NVIDIA Corporation (NVDA)
Fortress Biotech (FBIO)
Amazon (AMZN)
Female Health (VERU)
Pfizer (PFE)
Apple (AAPL)
Journey Med Corp (DERM)
Cardiol Therapeutics Inc- foreign (CRDL)
Ishares Etf Russell 2000 Etf (IWM)
SPDR Barclays Capital 1-3 month Etf (BIL)

View all positions for Pvg Asset Management

Top funds holding Anavex Life Sciences

BlackRock
Vanguard Group
State Street Corporation
Geode Capital Management
Susquehanna International
Nwam
Morgan Stanley
Two Sigma Investments
OZ Management
Northern Trust
Charles Schwab Investment Management
Citadel Advisors
Invesco
Goldman Sachs Group
Two Sigma Advisers

View all funds holding Anavex Life Sciences